A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.
暂无分享,去创建一个
N. Lee | N. Katabi | S. Baxi | A. Ho | R. Wong | D. Pfister | N. Riaz | S. McBride | E. Sherman | M. Fury | L. Michel | L. Dunn | S. Haque | Han Xiao